Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H M Bryson

Showing results (31-40 of 41) with videos related to

Pageof 5
Sort By:
Drugs|February 1, 1995
Cabergoline. A review of its pharmacological properties and therapeutic potential in the treatment of hyperprolactinaemia and inhibition of lactationC P Rains, H M Bryson, A Fitton
Pharmacoeconomics|July 7, 1992
Selegiline: an appraisal of the basis of its pharmacoeconomic and quality-of-life benefits in Parkinson's diseaseH M Bryson, R J Milne, P Chrisp
Drugs|April 1, 1996
Itraconazole. A reappraisal of its pharmacological properties and therapeutic use in the management of superficial fungal infectionsM Haria, H M Bryson, K L Goa
Drugs|September 1, 1995
Propofol. An update of its use in anaesthesia and conscious sedationH M Bryson, B R Fulton, D Faulds
Drugs|April 1, 1997
Fosfomycin tromethamine. A review of its antibacterial activity, pharmacokinetic properties and therapeutic efficacy as a single-dose oral treatment for acute uncomplicated lower urinary tract infectionsS S Patel, J A Balfour, H M Bryson
Pharmacoeconomics|July 7, 1994
Enalapril: a review of quality-of-life and pharmacoeconomic aspects of its use in heart failure and mild to moderate hypertensionM I Wilde, H M Bryson, K L Goa
Drugs|January 1, 1996
Imipenem/cilastatin: an update of its antibacterial activity, pharmacokinetics and therapeutic efficacy in the treatment of serious infectionsJ A Balfour, H M Bryson, R N Brogden
Drugs & Aging|January 1, 1996
Intracavernous alprostadil. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in erectile dysfunctionA P Lea, H M Bryson, J A Balfour
Drugs|April 1, 1995
Ceftazidime. An update of its antibacterial activity, pharmacokinetic properties and therapeutic efficacyC P Rains, H M Bryson, D H Peters
Drugs|January 1, 1993
Propafenone. A reappraisal of its pharmacology, pharmacokinetics and therapeutic use in cardiac arrhythmiasH M Bryson, K J Palmer, H D Langtry, et al.
Pageof 5

Showing results (31-40 of 41) with videos related to

Sort By:
Pageof 5
Drugs|February 1, 1995
Cabergoline. A review of its pharmacological properties and therapeutic potential in the treatment of hyperprolactinaemia and inhibition of lactationC P Rains, H M Bryson, A Fitton
Pharmacoeconomics|July 7, 1992
Selegiline: an appraisal of the basis of its pharmacoeconomic and quality-of-life benefits in Parkinson's diseaseH M Bryson, R J Milne, P Chrisp
Drugs|April 1, 1996
Itraconazole. A reappraisal of its pharmacological properties and therapeutic use in the management of superficial fungal infectionsM Haria, H M Bryson, K L Goa
Drugs|September 1, 1995
Propofol. An update of its use in anaesthesia and conscious sedationH M Bryson, B R Fulton, D Faulds
Drugs|April 1, 1997
Fosfomycin tromethamine. A review of its antibacterial activity, pharmacokinetic properties and therapeutic efficacy as a single-dose oral treatment for acute uncomplicated lower urinary tract infectionsS S Patel, J A Balfour, H M Bryson
Pharmacoeconomics|July 7, 1994
Enalapril: a review of quality-of-life and pharmacoeconomic aspects of its use in heart failure and mild to moderate hypertensionM I Wilde, H M Bryson, K L Goa
Drugs|January 1, 1996
Imipenem/cilastatin: an update of its antibacterial activity, pharmacokinetics and therapeutic efficacy in the treatment of serious infectionsJ A Balfour, H M Bryson, R N Brogden
Drugs & Aging|January 1, 1996
Intracavernous alprostadil. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in erectile dysfunctionA P Lea, H M Bryson, J A Balfour
Drugs|April 1, 1995
Ceftazidime. An update of its antibacterial activity, pharmacokinetic properties and therapeutic efficacyC P Rains, H M Bryson, D H Peters
Drugs|January 1, 1993
Propafenone. A reappraisal of its pharmacology, pharmacokinetics and therapeutic use in cardiac arrhythmiasH M Bryson, K J Palmer, H D Langtry, et al.
Pageof 5